NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Technical Officer Eliana Clark sold $225K of Intellia Therapeutics, Inc.
Sold$225,000
$45.00Price
5,000Shares
−10%Stake
What NTLA did after the filing
- The stock from Thu, Jun 22 close, $41.98
- −5.6%
- S&P 500, same days
- +2.4%
Measured over 30 trading days, to the Aug 4 close.
Traded Tue, Jun 20. Filed Thu, Jun 22, 1:52 PM ET, during the session. Returns use the Jun 22 close and the Aug 4 close. Not investment advice.